Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01798186 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT01798186: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT01798186 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01798186, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This primary aim of this study is to assess the effects of passive (second-hand) inhalation of cannabis smoke on toxicological analysis of "native" oral fluid (saliva), urine and blood specimens. The results of this study will help inform the validity of oral fluid as a biomarker of cannabis exposure and to determine whether, and for how long, passive inhalation of cannabis smoke could result in a positive toxicology result.
Interventions
- DRUG Cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2013-05 |
| Est. Completion | 2013-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01798186
The ClinicalTrials.gov registry entry for NCT01798186 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabis is the first listed.
NCT01798186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01798186 about?
NCT01798186 is a clinical study titled "Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation". This primary aim of this study is to assess the effects of passive (second-hand) inhalation of cannabis smoke on toxicological analysis of "native" oral fluid (saliva), urine and blood specimens. The results of this study will help inform the validity of oral fluid as a biomarker of cannabis exposur...
What is the current status of trial NCT01798186?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2013-05. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01798186?
The interventions under investigation include: Cannabis (DRUG).
Who is sponsoring clinical trial NCT01798186?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.